Publication | Closed Access

A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis

Central Neuropathic PainPain TherapyHealth SciencesPain MedicineMedicineClinical TrialsNeuropathic PainNeuropharmacologyPharmacotherapyPain ManagementNeurologyMultiple SclerosisThc/cbd Oromucosal SprayPharmacologyPain Research